Serum Bovine Immunoglobulin for Chemotherapy-Induced Gastrointestinal Mucositis

Am J Hosp Palliat Care. 2018 May;35(5):814-817. doi: 10.1177/1049909117735831. Epub 2017 Oct 11.

Abstract

Cancer treatments including chemotherapy and radiotherapy treat cancer by targeting rapidly dividing cells. Although these forms of treatment damage rapidly dividing cancer cells, they are also toxic to the cells of the gastrointestinal tract, leading to inflammation of the mucosal layer (mucositis) and causing nausea, vomiting, diarrhea, and abdominal pain. Improvement in symptoms may allow patients to have better performance status permitting ongoing treatment and possibly a better prognosis. This article describes the pathophysiology of chemotherapy-induced mucositis and includes 3 case reports of treatment of mucositis with serum bovine immunoglobulin.

Keywords: adverse effects; chemotherapy; chemotherapy-induced mucositis; inflammatory bowel disease; irritable bowel syndrome; mucositis; serum bovine immunoglobulin; therapy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / adverse effects*
  • Female
  • Gastrointestinal Diseases / chemically induced*
  • Gastrointestinal Diseases / drug therapy*
  • Humans
  • Immunoglobulins / therapeutic use*
  • Mucositis / chemically induced*
  • Mucositis / drug therapy*
  • Neoplasms / drug therapy

Substances

  • Antineoplastic Agents
  • Immunoglobulins